• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于细胞的 CAR 疗法:文献计量学和专利分析评估。

CAR-based cell therapy: evaluation with bibliometrics and patent analysis.

机构信息

Zhejiang Academy of Science and Technology Information, Hangzhou, China.

School of Medicine, The First Affiliated Hospital of Zhejiang University, Hangzhou, China.

出版信息

Hum Vaccin Immunother. 2021 Nov 2;17(11):4374-4382. doi: 10.1080/21645515.2021.1947100. Epub 2021 Jun 29.

DOI:10.1080/21645515.2021.1947100
PMID:34184975
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8827635/
Abstract

Chimeric antigen receptors-based cell therapies have shown impressive preclinical and clinical success and revolutionized biomedicine. However, the link between science and invention, the impact of international cooperation, and the influence and prestige of CARs research have not been explored. This study analyzed the landscape of peer-reviewed articles and patents related to CARs. A total of 5,681 publications were analyzed using bibliometrics and machine learning-based text mining to assess publication metrics, subject areas, and research hotspots. 5,010 Inpadoc families were also analyzed for patent filing trends, priority countries, and applicant and inventor rankings. The results show that CARs research has the following distinctive features: high research prestige among research community; strong global geographical bias in both academic output and patenting patterns; strong links between science and invention, but significant differences among countries; and an inverse relationship between country size and international collaboration rates.

摘要

嵌合抗原受体细胞疗法在临床前和临床方面取得了令人瞩目的成功,彻底改变了生物医学领域。然而,科学与发明之间的联系、国际合作的影响以及 CAR 研究的影响力和声望尚未得到探索。本研究分析了与 CAR 相关的同行评审文章和专利的全景。利用文献计量学和基于机器学习的文本挖掘分析了 5681 篇出版物,以评估出版物指标、主题领域和研究热点。还分析了 5010 个 Inpadoc 家族的专利申请趋势、优先国家、申请人和发明人排名。结果表明,CAR 研究具有以下显著特征:在研究界具有很高的研究声望;学术产出和专利模式都存在强烈的全球地域偏见;科学与发明之间联系紧密,但各国之间存在显著差异;国家规模与国际合作率呈反比关系。

相似文献

1
CAR-based cell therapy: evaluation with bibliometrics and patent analysis.基于细胞的 CAR 疗法:文献计量学和专利分析评估。
Hum Vaccin Immunother. 2021 Nov 2;17(11):4374-4382. doi: 10.1080/21645515.2021.1947100. Epub 2021 Jun 29.
2
Human gene therapy: A scientometric analysis.人类基因治疗:一项科学计量学分析。
Biomed Pharmacother. 2021 Jun;138:111510. doi: 10.1016/j.biopha.2021.111510. Epub 2021 Mar 23.
3
Bibliometric Analysis of Chimeric Antigen Receptor-Based Immunotherapy in Cancers From 2001 to 2021.2001 年至 2021 年基于嵌合抗原受体的免疫疗法治疗癌症的文献计量学分析。
Front Immunol. 2022 Mar 30;13:822004. doi: 10.3389/fimmu.2022.822004. eCollection 2022.
4
Global hotspots and future prospects of chimeric antigen receptor T-cell therapy in cancer research: a bibliometric analysis.全球癌症研究中嵌合抗原受体 T 细胞疗法的热点和未来展望:文献计量分析。
Future Oncol. 2020 Apr;16(10):597-612. doi: 10.2217/fon-2019-0810. Epub 2020 Mar 24.
5
A Bibliometric and Knowledge-Map Analysis of CAR-T Cells From 2009 to 2021.2009 年至 2021 年嵌合抗原受体 T 细胞的文献计量学和知识图谱分析。
Front Immunol. 2022 Mar 18;13:840956. doi: 10.3389/fimmu.2022.840956. eCollection 2022.
6
Efficacy and safety of CD22 chimeric antigen receptor (CAR) T cell therapy in patients with B cell malignancies: a protocol for a systematic review and meta-analysis.嵌合抗原受体(CAR)T 细胞治疗 B 细胞恶性肿瘤患者的疗效和安全性的系统评价和荟萃分析方案。
Syst Rev. 2021 Jan 21;10(1):35. doi: 10.1186/s13643-021-01588-7.
7
The global chimeric antigen receptor T (CAR-T) cell therapy patent landscape.全球嵌合抗原受体T(CAR-T)细胞疗法的专利情况。
Nat Biotechnol. 2020 Dec;38(12):1387-1394. doi: 10.1038/s41587-020-00749-8.
8
Emerging CAR T cell therapies: clinical landscape and patent technological routes.新兴的嵌合抗原受体T细胞疗法:临床概况与专利技术路线
Hum Vaccin Immunother. 2020 Jun 2;16(6):1424-1433. doi: 10.1080/21645515.2019.1689744. Epub 2019 Dec 6.
9
Internet of Things in Health Trends Through Bibliometrics and Text Mining.通过文献计量学和文本挖掘看物联网在健康领域的发展趋势
Stud Health Technol Inform. 2017;235:73-77.
10
Publication analysis in Bay for Bengal Initiative for Multi-Sectoral Technical and Economic Cooperation Nations.孟加拉湾多部门技术和经济合作倡议国家的出版物分析。
F1000Res. 2021 Jun 28;10:510. doi: 10.12688/f1000research.52286.1. eCollection 2021.

引用本文的文献

1
Horizon Scanning Methods for Health Care Technology Innovation Identification: Rapid Scoping Review of Patent Research Studies.用于识别医疗保健技术创新的地平线扫描方法:专利研究的快速范围综述
Interact J Med Res. 2025 Sep 11;14:e70323. doi: 10.2196/70323.
2
Knowledge-map and bibliometric analysis of scientific research on FDA-approved Chimeric Antigen Receptor T cell products (2015-2024).美国食品药品监督管理局(FDA)批准的嵌合抗原受体T细胞产品的科学研究知识图谱与文献计量分析(2015 - 2024年)
Discov Oncol. 2025 Aug 3;16(1):1461. doi: 10.1007/s12672-025-03360-y.
3
Current status and future prospects of chimeric antigen receptor-T cell therapy in lymphoma research: A bibliometric analysis.嵌合抗原受体-T 细胞疗法在淋巴瘤研究中的现状和未来前景:文献计量分析。
Hum Vaccin Immunother. 2023 Dec 15;19(3):2267865. doi: 10.1080/21645515.2023.2267865. Epub 2023 Oct 16.
4
Worldwide research trends on femur head necrosis (2000-2021): a bibliometrics analysis and suggestions for researchers.全球股骨头坏死研究趋势(2000 - 2021):文献计量学分析及给研究者的建议
Ann Transl Med. 2023 Feb 15;11(3):155. doi: 10.21037/atm-23-303.

本文引用的文献

1
Quantifying the publication preferences of leading research universities.量化顶尖研究型大学的发表偏好。
Scientometrics. 2021;126(3):2269-2310. doi: 10.1007/s11192-020-03790-1. Epub 2021 Jan 4.
2
Outlook for New CAR-Based Therapies with a Focus on CAR NK Cells: What Lies Beyond CAR-Engineered T Cells in the Race against Cancer.新型 CAR 疗法的前景,重点关注 CAR-NK 细胞:在对抗癌症的竞赛中,CAR 工程化 T 细胞之外的未来。
Cancer Discov. 2021 Jan;11(1):45-58. doi: 10.1158/2159-8290.CD-20-0556. Epub 2020 Dec 4.
3
Next-generation cell therapies: the emerging role of CAR-NK cells.下一代细胞疗法:CAR-NK 细胞的新兴作用。
Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):570-578. doi: 10.1182/hematology.2020002547.
4
The global chimeric antigen receptor T (CAR-T) cell therapy patent landscape.全球嵌合抗原受体T(CAR-T)细胞疗法的专利情况。
Nat Biotechnol. 2020 Dec;38(12):1387-1394. doi: 10.1038/s41587-020-00749-8.
5
Current status and future development of anti-HIV chimeric antigen receptor T-cell therapy.抗 HIV 嵌合抗原受体 T 细胞治疗的现状和未来发展。
Immunotherapy. 2021 Feb;13(2):177-184. doi: 10.2217/imt-2020-0199. Epub 2020 Nov 23.
6
Clinical development of CAR T cell therapy in China: 2020 update.中国嵌合抗原受体 T 细胞治疗的临床开发:2020 更新版。
Cell Mol Immunol. 2021 Apr;18(4):792-804. doi: 10.1038/s41423-020-00555-x. Epub 2020 Sep 30.
7
Dual-function chimeric antigen receptor T cells targeting c-Met and PD-1 exhibit potent anti-tumor efficacy in solid tumors.靶向 c-Met 和 PD-1 的双功能嵌合抗原受体 T 细胞在实体瘤中显示出强大的抗肿瘤疗效。
Invest New Drugs. 2021 Feb;39(1):34-51. doi: 10.1007/s10637-020-00978-3. Epub 2020 Aug 8.
8
Engineering CAR-T Cells for Next-Generation Cancer Therapy.工程化 CAR-T 细胞用于下一代癌症治疗。
Cancer Cell. 2020 Oct 12;38(4):473-488. doi: 10.1016/j.ccell.2020.07.005. Epub 2020 Jul 30.
9
Safety and efficacy of chimeric antigen receptor (CAR)-T-cell therapy in persons with advanced B-cell cancers and hepatitis B virus-infection.嵌合抗原受体 (CAR)-T 细胞疗法在患有晚期 B 细胞癌症和乙型肝炎病毒感染的人群中的安全性和有效性。
Leukemia. 2020 Oct;34(10):2704-2707. doi: 10.1038/s41375-020-0936-4. Epub 2020 Jun 27.
10
Global hotspots and future prospects of chimeric antigen receptor T-cell therapy in cancer research: a bibliometric analysis.全球癌症研究中嵌合抗原受体 T 细胞疗法的热点和未来展望:文献计量分析。
Future Oncol. 2020 Apr;16(10):597-612. doi: 10.2217/fon-2019-0810. Epub 2020 Mar 24.